Ana Sebrango

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study

Javier de la Rubia, Federico Moscardó, María Gómez et al. · Transfusion and Apheresis Science · 2010 · 59 citations

Medicine, Hematology, Immunology +9

Haematopoietic transplants combining a single unrelated cord blood unit and mobilized haematopoietic stem cells from an adult HLA-mismatched third party donor.

Ana Sebrango, Isabel Vicuña, Almudena de Laiglesia et al. · Best Practice & Research Clinical Haematology · 2010 · 31 citations

Medicine, Hematology, Immunology +17

Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients

Valentín García‐Gutiérrez, Dragana Milojković, Juan Carlos Hernández‐Boluda et al. · Annals of Hematology · 2018 · 26 citations

Medicine, Hematology, Pharmacology +7

COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

Joaquín Martínez‐López, Rodrigo Gil-Manso, Adrían Alegre et al. · Cancers · 2023 · 21 citations · Full text

Medicine, Hematology, Oncology +11

Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the <scp>S</scp>panish compassionate use program

Valentín García‐Gutiérrez, Alejandra Martínez‐Trillos, José Luis López Lorenzo et al. · American Journal of Hematology · 2015 · 20 citations · Full text

Medicine, Hematology, Pharmacology +10